Abstract
BACKGROUND--Cryptogenic fibrosing alveolitis (synonymous with idiopathic pulmonary fibrosis) is a clinically heterogeneous condition in which the precipitating factor is unclear. Both environmental and infective factors have been implicated. An association between Epstein-Barr virus (EBV) and cryptogenic fibrosing alveolitis was suggested over a decade ago by a study based on EBV serology, but the significance of this has been unclear. METHODS--Lung tissue obtained surgically from patients (n = 20) with cryptogenic fibrosing alveolitis was investigated for evidence of EBV replication and compared with lung tissue from 21 control patients. Fourteen of the 20 patients had received no specific therapy for cryptogenic fibrosing alveolitis at the time of biopsy. Monoclonal antibodies directed against the EBV viral antigens, EBV viral capsid antigen (VCA) and gp 340/220 antigen, which are expressed during the lytic phase of the EBV life cycle, were studied. RESULTS--Fourteen (70%) of the 20 patients with cryptogenic fibrosing alveolitis were positive for both EBV VCA and gp 340/220 compared with two (9%) of the 21 controls. In the patients with cryptogenic fibrosing alveolitis viral replication was localised to pulmonary epithelial cells using epithelial cell markers, and immunohistochemical analysis confirmed the staining to be within type II alveolar cells. CONCLUSIONS--This is the first report of in vivo EBV replication within epithelial cells of the lower respiratory tract in an immunocompetent human host. Furthermore, this suggests that EBV may be an immune trigger or contribute to lung injury in cryptogenic fibrosing alveolitis, thus offering a potential new avenue of treatment.
Full text
PDF





Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ashcroft T., Simpson J. M., Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol. 1988 Apr;41(4):467–470. doi: 10.1136/jcp.41.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Billings C. G., Howard P. Hypothesis: exposure to solvents may cause fibrosing alveolitis. Eur Respir J. 1994 Jun;7(6):1172–1176. [PubMed] [Google Scholar]
- Carrigan D. R., Drobyski W. R., Russler S. K., Tapper M. A., Knox K. K., Ash R. C. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet. 1991 Jul 20;338(8760):147–149. doi: 10.1016/0140-6736(91)90137-e. [DOI] [PubMed] [Google Scholar]
- Clemens M. J. The small RNAs of Epstein-Barr virus. Mol Biol Rep. 1993 Feb;17(2):81–92. doi: 10.1007/BF00996215. [DOI] [PubMed] [Google Scholar]
- Fujinami R. S., Nelson J. A., Walker L., Oldstone M. B. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol. 1988 Jan;62(1):100–105. doi: 10.1128/jvi.62.1.100-105.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gosselin J., Menezes J., D'Addario M., Hiscott J., Flamand L., Lamoureux G., Oth D. Inhibition of tumor necrosis factor-alpha transcription by Epstein-Barr virus. Eur J Immunol. 1991 Jan;21(1):203–208. doi: 10.1002/eji.1830210130. [DOI] [PubMed] [Google Scholar]
- Henle W., Henle G. Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res. 1981 Nov;41(11 Pt 1):4222–4225. [PubMed] [Google Scholar]
- Hoffman G. J., Lazarowitz S. G., Hayward S. D. Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen. Proc Natl Acad Sci U S A. 1980 May;77(5):2979–2983. doi: 10.1073/pnas.77.5.2979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hoffmann D. G., Gedebou M., Jimenez A., Nichols W. S., Marchevsky A. Detection of Epstein-Barr virus by polymerase chain reaction in transbronchial biopsies of lung transplant recipients: evidence of infection? Mod Pathol. 1993 Sep;6(5):555–559. [PubMed] [Google Scholar]
- Holmes G. P., Kaplan J. E., Stewart J. A., Hunt B., Pinsky P. F., Schonberger L. B. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA. 1987 May 1;257(17):2297–2302. [PubMed] [Google Scholar]
- Horan M. A. Immunosenescence and mucosal immunity. Lancet. 1993 Mar 27;341(8848):793–794. doi: 10.1016/0140-6736(93)90566-y. [DOI] [PubMed] [Google Scholar]
- Howe J. G., Steitz J. A. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9006–9010. doi: 10.1073/pnas.83.23.9006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jimenez S. A. New insights into the pathogenesis of interstitial pulmonary fibrosis. Thorax. 1994 Mar;49(3):193–195. doi: 10.1136/thx.49.3.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnston I., Britton J., Kinnear W., Logan R. Rising mortality from cryptogenic fibrosing alveolitis. BMJ. 1990 Nov 3;301(6759):1017–1021. doi: 10.1136/bmj.301.6759.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lung M. L., Lam W. K., So S. Y., Lam W. P., Chan K. H., Ng M. H. Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet. 1985 Apr 20;1(8434):889–892. doi: 10.1016/s0140-6736(85)91671-x. [DOI] [PubMed] [Google Scholar]
- MacMahon E. M., Glass J. D., Hayward S. D., Mann R. B., Becker P. S., Charache P., McArthur J. C., Ambinder R. F. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 1991 Oct 19;338(8773):969–973. doi: 10.1016/0140-6736(91)91837-k. [DOI] [PubMed] [Google Scholar]
- Matsui R., Goldstein R. H., Mihal K., Brody J. S., Steele M. P., Fine A. Type I collagen formation in rat type II alveolar cells immortalised by viral gene products. Thorax. 1994 Mar;49(3):201–206. doi: 10.1136/thx.49.3.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Millar A. B., Patou G., Miller R. F., Grundy J. E., Katz D. R., Weller I. V., Semple S. J. Cytomegalovirus in the lungs of patients with AIDS. Respiratory pathogen or passenger? Am Rev Respir Dis. 1990 Jun;141(6):1474–1477. doi: 10.1164/ajrccm/141.6.1474. [DOI] [PubMed] [Google Scholar]
- Niedobitek G., Young L. S. Epstein-Barr virus persistence and virus-associated tumours. Lancet. 1994 Feb 5;343(8893):333–335. doi: 10.1016/s0140-6736(94)91167-3. [DOI] [PubMed] [Google Scholar]
- Niedobitek G., Young L. S., Lau R., Brooks L., Greenspan D., Greenspan J. S., Rickinson A. B. Epstein-Barr virus infection in oral hairy leukoplakia: virus replication in the absence of a detectable latent phase. J Gen Virol. 1991 Dec;72(Pt 12):3035–3046. doi: 10.1099/0022-1317-72-12-3035. [DOI] [PubMed] [Google Scholar]
- Revoltella R. P., Vigneti E., Fruscalzo A., Park M., Ragona G., Rocchi G., Calef E. Epstein-Barr virus DNA sequences in precursor monocyte-macrophage cell lines established from the bone marrow of children with maturation defects of haematopoiesis. J Gen Virol. 1989 May;70(Pt 5):1203–1215. doi: 10.1099/0022-1317-70-5-1203. [DOI] [PubMed] [Google Scholar]
- Scott J., Johnston I., Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ. 1990 Nov 3;301(6759):1015–1017. doi: 10.1136/bmj.301.6759.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sixbey J. W., Nedrud J. G., Raab-Traub N., Hanes R. A., Pagano J. S. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med. 1984 May 10;310(19):1225–1230. doi: 10.1056/NEJM198405103101905. [DOI] [PubMed] [Google Scholar]
- Stewart J. P., Arrand J. R. Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens. Hum Pathol. 1993 Mar;24(3):239–242. doi: 10.1016/0046-8177(93)90032-c. [DOI] [PubMed] [Google Scholar]
- Stewart J. P., Hampson I. N., Heinrich H. W., Mackett M., Arrand J. R. Enhanced expression of the Epstein-Barr virus latent membrane protein by a recombinant vaccinia virus. J Gen Virol. 1989 May;70(Pt 5):1231–1237. doi: 10.1099/0022-1317-70-5-1231. [DOI] [PubMed] [Google Scholar]
- Sunil-Chandra N. P., Efstathiou S., Arno J., Nash A. A. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J Gen Virol. 1992 Sep;73(Pt 9):2347–2356. doi: 10.1099/0022-1317-73-9-2347. [DOI] [PubMed] [Google Scholar]
- Vergnon J. M., Vincent M., de Thé G., Mornex J. F., Weynants P., Brune J. Cryptogenic fibrosing alveolitis and Epstein-Barr virus: an association? Lancet. 1984 Oct 6;2(8406):768–771. doi: 10.1016/s0140-6736(84)90702-5. [DOI] [PubMed] [Google Scholar]